title: Enhancement of the efficacy of x-irradiation by pentobarbital in a rodent brain-tumor model.
abstract: Radiation therapy is an important component of brain tumor treatment, but its efficacy is limited by its toxicity to the surrounding normal tissue. Pentobarbital acts as a cerebral radioprotectant, but the selectivity of its protection for the central nervous system has not been demonstrated. To determine if pentobarbital also protects tumor against ionizing radiation, five groups of Fischer 344 rats were observed after exposure to varying combinations of the presence or absence of implanted tumor, pentobarbital, and radiation treatment. The first three groups underwent cerebral implantations of a suspension of 9L gliosarcoma cells. Group 1 was left untreated and served as tumor-bearing controls. Group 2 received 30 Gy of whole-brain x-irradiation without anesthesia 8 days after tumor implantation. Group 3 received the same radiation treatment 15 minutes after pretreatment with 60 mg/kg of pentobarbital intraperitoneally. Groups 4 and 5 served as radiation controls, receiving 30 Gy of x-irradiation while awake and 30 Gy of x-irradiation after pentobarbital administration, respectively. Survival was calculated from the death of the last tumor-bearing rat. The mean survival time in tumor-bearing control rats was 20.8 +/- 2.6 days (+/- standard deviation). X-irradiation alone significantly enhanced the period of survival in rats implanted with the 9L tumor (29.7 +/- 5.6 days, p less than 0.03). Further significant prolongation of survival was seen with the addition of pentobarbital to the treatment regimen (39.9 +/- 13.5 days, p less than 0.01). Nontumor-bearing rats irradiated while awake (Group 4) survived 30.9 +/- 2.3 days. All of their pentobarbital-anesthetized counterparts in Group 5 survived. If pentobarbital had offered radioprotection to the tumor, then Group 3 would have had a shorter survival period than Group 2. This implies that the enhancement of survival time after irradiation results from selective protection of normal brain in this model.
authors.affiliation: Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
authors.forename: J J
authors.initials: JJ
authors.lastname: Olson
authors.forename: R
authors.initials: R
authors.lastname: Friedman
authors.forename: K
authors.initials: K
authors.lastname: Orr
authors.forename: T
authors.initials: T
authors.lastname: Delaney
authors.forename: E H
authors.initials: EH
authors.lastname: Oldfield
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000528:radiation effects; D001932:Brain Neoplasms / Q000532:radiotherapy*; D004195:Disease Models, Animal; D005910:Glioma / Q000532:radiotherapy*; D008297:Male; D010424:Pentobarbital / Q000627:therapeutic use*; D011837:Radiation-Protective Agents; D051381:Rats; D011916:Rats, Inbred F344; D015996:Survival Rate
chemical_list: D011837:Radiation-Protective Agents; D010424:Pentobarbital